Physician profile
Benjamin R Jacobs
NPI 1235176942
$702.61
in general payments reported to CMS, 2019-2025
14 companies · $189 in 2025
The $189 reported for 2025 was more than what 80% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $37.37 · 2021: $14.19 · 2022: $28.40 · 2024: $206 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $142.57 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $84.58 | 2024-2025 | Ninlaro, Fruzaqla |
| Lilly USA, LLC | $77.00 | 2019 | |
| Caris Mpi, INC. | $64.20 | 2025 | Mi Cancer Seek |
| Janssen Biotech, INC. | $60.03 | 2019 | |
| Puma Biotechnology, INC. | $54.84 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $48.53 | 2019 | |
| Eisai INC. | $40.77 | 2024 | |
| Pfizer INC. | $28.40 | 2022 | |
| Daiichi Sankyo INC. | $24.59 | 2020 | |
| Apellis Pharmaceuticals, INC. | $24.55 | 2025 | Empaveli |
| Gilead Sciences, INC. | $21.06 | 2025 | Trodelvy |
| Emd Serono, INC. | $17.30 | 2024 | |
| Innocoll Pharmaceuticals Limited | $14.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.